← All organizations
Acquired by SmithKline Beckman → SmithKline Beecham → GlaxoSmithKline on Jan 1, 1982
Timeline
1890s
- Jan 1, 1891
Smith, Kline & French— Founded
- Jan 1, 1891
Smith and Shoemaker— Acquired
1950s
- Sep 16, 1957
triflupromazine— NDA Organization
1980s
- Jan 1, 1982
SmithKline Beckman— Acquired By
- Jan 1, 1982
Allergan— Acquired
2000s
- Jan 1, 2000
GlaxoSmithKline— Now
Drugs by trial phase (148 distinct, 608 trials)
Phase 4 (0 own, 64 via acquisition)
Phase 3 (0 own, 34 via acquisition)
Phase 2 (0 own, 30 via acquisition)
Phase 1 (0 own, 16 via acquisition)
Other trials (0 own, 4 via acquisition)
Indications
Approved for
- Adams-Stokes Syndrome
- Bronchial Spasm
- Endocarditis
- Eye Diseases
- Heart Arrest
- Heart Block
- Hypersensitivity
- Hypotension
- Infections
- Leukemia, Myeloid, Acute
- Migraine Disorders
- Nausea
- Porphyria, Acute Intermittent
- Premenstrual Syndrome
- Prostatitis
- Pruritus
- Psychotic Disorders
- Respiratory Tract Infections
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Seasonal
- Schizophrenia
- Sepsis
- Sinusitis
- Urinary Tract Infections
Marketed drugs (10)
Subsidiaries (2 direct, 10 total across the full acquisition tree)
Details
- Founded
- Philadelphia, PA, US Jan 1, 1891
- First NDA
- Sep 16, 1957
- Last known activity
- Jun 1, 1971
Designations held
- Priority review